Svetlana Lucas

Svetlana Lucas

Director/Miembro de la Junta en ATYR PHARMA, INC. .

Fortuna: 19 838 $ al 31/05/2026

54 años
Health Technology
Consumer Services

Perfil

Dr. Svetlana Lucas is an Independent Director at Jasper Therapeutics, Inc., an Independent Director at aTyr Pharma, Inc. and a Chief Business Officer at Scribe Therapeutics, Inc. She is on the Board of Directors at Jasper Therapeutics, Inc. and aTyr Pharma, Inc. Dr. Lucas was previously employed as a Senior Vice President-Business Development by Tizona Therapeutics, Inc. and a Head-Oncology & Inflammation by Amgen, Inc. She received her undergraduate degree from Moscow State University Lomonosov and a doctorate degree from California Institute of Technology.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
01/06/2026 20.000 ( 0,07 % ) 16 580 $ 31/05/2026
11/05/2026 6.000 ( 0,01 % ) 3 258 $ 31/05/2026

Cargos activos de Svetlana Lucas

EmpresasCargoInicio
ATYR PHARMA, INC. Director/Miembro de la Junta 28/06/2019
JASPER THERAPEUTICS, INC. Director/Miembro de la Junta 19/06/2024
Corporate Officer/Principal 01/06/2019

Antiguos cargos conocidos de Svetlana Lucas.

EmpresasCargoFin
Corporate Officer/Principal 01/01/2019
AMGEN INC. Corporate Officer/Principal 01/07/2015
Ver el detalle de la experiencia de Svetlana Lucas.

Formación de Svetlana Lucas.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

70

Relaciones de 1er grado

7

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas7

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology